Modern Healthcare reports that Winston-Salem health system Novant Health has named Mark J. King Vice President of Research and Innovation starting early March 2019. King previously led oncology clinical trials at Atrium Health’s Levine Cancer Institute.
At Novant Health, King will work with physician leaders across the 15-hospital system to improve patient access to clinical trials, according to a news release. He will work side-by-side with Dr. Steven Limentani, Novant Health’s senior vice president of oncology, to expand the health system’s clinical research portfolio and develop relationships with pharmaceutical companies and device manufacturers, as well as academic research centers.
At Novant Health clinical research Clinical trials are part of medical research, and they are at the heart of all medical advances. They use this method of research to find new ways to prevent, detect or treat diseases. Their research may be used to study new drugs or new drug combinations, new ways to use existing treatments or new surgical procedures or devices. They are devoted to providing patients with the best medical treatments and medication possible. The research conducted at Novant Health enables them to serve our community with innovative treatments and progressive healthcare before it is widely available.